New anti–vascular endothelial growth factor (VEGF) therapies are improving retinal disease management by providing patients ...

Continuous administration of ranibizumab with a port delivery system provides an alternative to frequent intravitreal ...

MOUNTAIN VIEW, Calif., March 14, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for ...

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced their abstract of a preclinical study of KIO ...

Additionally, the prognosis of macular edema may help clinicians evaluate renal function, investigators reported ...